Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Closes
- Nov 23, 2026 (in 44 days)
Similar opportunities open now
- Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)Same funderOpenNational Institutes of HealthCloses Nov 23, 2026 (in 44 days)
- Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses Nov 23, 2026 (in 44 days)
- Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)Same funderOpenNational Institutes of HealthCloses Nov 2028
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)Same funderOpenNational Institutes of HealthCloses Oct 30, 2026 (in 20 days)Up to $1.3M
- Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)Same funderOpenNational Institutes of HealthCloses May 2027Up to $500K
Classification and identifiers
- Solicitation number
- RFA-RM-27-016
- Assistance listing (CFDA)
- 93.310
Amount
Amount not listed here. Check the official program.
Who can apply
State government agencies and Public colleges and universities can all apply here. Check the eligibility details below to see if your organization fits.
About this opportunity
The NIH Common Fund, National Institute on Aging, National Cancer Institute and additional NIH Institutes and Centers (ICs) intend to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Stage 2 of the Cellular Senescence Network (SenNet) Program, which seeks to understand the biological consequences of senescent cell heterogeneity in health and disease, identify and characterize tissue-specific senescence markers in human biospecimens to facilitate the development of senotherapeutic strategies that improve health outcomes. The program’s SenNet Data Coordination, Integration and Organizational Center (DCIOC) will integrate tissue mapping efforts with Stage 2 data to generate Atlases of Senescence incorporating the spatial distribution of senescence biomarkers with bio...